Biologics Safety Testing Market by Product & Service (Instruments, Consumables, Services), Application (mAbs, Vaccine, Cell & Gene Therapy), Test Type (Sterility Test, Endotoxin, Mycoplasma, Bioburden), End User (Biopharma, CDMO) - Global Forecast to 2027

Publisher Name :
Date: 25-Jan-2023
No. of pages: 249
Inquire Before Buying

“Increased research and development in the biopharmaceutical industry is set to drive the Biologics Saftey Testing market.’’

The global biologics safety testing market is projected to reach USD 6.8 billion by 2027 from USD 3.6 billion in 2022, at a CAGR of 13.3% during the forecast period. The growth of the global biologics safety testing market is driven by factors such as the strict regulatory scenario implemented for quality control testing for biopharmaceutical production, increase in the number of approved biologics products worldwide, growing use of biologics safety testing reagents and kits for cell culture contamination detection, and increases in R&D spending and government support will significantly boost biologics testing activities.

“By product & service segment, the service segment accounted for the largest share of the Biologics Safety Testing market”

Based on product and service, the biologics safety testing market is segmented into consumables, services, and instruments. In 2021, the services segment accounted for the largest market share. The large share of this segment can be attributed to large biopharmaceutical companies routinely outsource numerous tasks, such as process and product validation, process monitoring and quality control, toxicology, and other preclinical studies.

”By application, the monoclonal antibodies development and manufacturing segment accounted for the largest market share of the Biologics safety testing market “

Based on application, the biologics safety testing market is segmented into monoclonal antibodies development and manufacturing, vaccines development and manufacturing, blood and blood products development and manufacturing, cellular and gene therapy products development and manufacturing, and other applications. In 2021, the monoclonal antibodies development and manufacturing segment accounted for the largest market share. The large share of this segment can be attributed to the growing number of regulatory approvals.

“Asia Pacific: The fastest-growing region in the biologics safety testing market.”

The biologics safety testing market in the Asia Pacific region is projected to register the highest growth during the forecast period. Factors such as growth in the outsourcing industry in the Asia Pacific region, vastly expanding R&D funding by biopharmaceutical companies and government, minimized outsourcing costs, and rising patient population resulting in growing manufacturing of biologics are expected to drive market growth.

“North America accounted for the largest share of the Biologics safety testing market in 2021” 

North America accounted for the largest share of the biologics safety testing market in 2021. Rapid growth in the biopharmaceutical industry is the major factor driving the growth of the North American biologics safety testing market. High number of pre-registration and other-phase drugs in the pipeline by pharmaceutical companies and biotechnology/gene therapy/genomics companies and the presence of major market players in this region are also driving the market for biologics safety testing in North America.

 

 

Breakdown of primaries

 

The study contains insights from various industry experts, ranging from component suppliers to Tier 1 companies and OEMs. The break-up of the primaries is as follows:

 


  • By Respondent– Supply Side- 80%, Demand Side-20%

  • By Designation— CXOs - 20%, Executives - 25%, Mangers - 55%

  • By Region— North America - 40%, Europe - 30%, APAC – 20%, LATAM & MEA- 10%


 

The Biologics Safety Testing market is dominated by a few globally established players such Charles River Laboratories, Inc. (US), Lonza (Switzerland), Thermo Fisher Scientific, Inc. (US), Merck KGaA (Germany), F. Hoffmann-La Roche Ltd. (Switzerland), Agilent Technologies, Inc. (US), Labcorp (US), SGS SA (Switzerland), WuXi AppTec (China), Sartorius AG (Germany), Associates of Cape Cod, Inc. (US), bioMérieux SA (France), Eurofins Scientific (Luxembourg), FUJIFILM Wako Pure Chemical Corporation (Japan), Almac Group (UK), Bio-Rad Laboratories, Inc. (US), QIAGEN (Germany) , Pacific BioLabs (US), InvivoGen (US), Microcoat Biotechnologie GmbH (Germany), PromoCell GmbH (Germany), Samsung Biologics (South Korea), GenScript (China), Maravai Lifesciences (US), Accugen Laboratories, Inc. (US) and Nelson Laboratories, LCC (US)

Research Coverage:

The report segments the Biologics Safety Testing market based on region (Asia Pacific, Europe, North America, Latin America and Middle East and Africa), product and service (consumables, services, and instruments), application (monoclonal antibodies development and manufacturing, vaccines development and manufacturing, blood and blood products development and manufacturing, cellular and gene therapy products development and manufacturing, and other applications.), and test types (endotoxin tests, sterility tests, mycoplasma tests, bioburden tests, virus safety tests, residual host-cell proteins and DNA detection tests, and other biologics safety tests). The report also provides a comprehensive review of market drivers, opportunities, challenges and restrains in the Biologics Safety Testing market.

Key Benefits of Buying the Report:

The report will help the leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall market and the sub-segments. This report will help stakeholders understand the competitive landscape and gain more insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the Biologics Safety Testing market and provides them information on key market drivers, restraints, challenges, and opportunities.

Biologics Safety Testing Market by Product & Service (Instruments, Consumables, Services), Application (mAbs, Vaccine, Cell & Gene Therapy), Test Type (Sterility Test, Endotoxin, Mycoplasma, Bioburden), End User (Biopharma, CDMO) - Global Forecast to 2027

Table Of Contents

1 Introduction 30
1.1 Study Objectives 30
1.2 Market Definition 30
1.2.1 Inclusions And Exclusions 31
1.2.2 Markets Covered 32
Figure 1 Biologics Safety Testing Market Segmentation 32
1.2.3 Years Considered 32
1.3 Currency Considered 33
1.4 Limitations 33
1.5 Stakeholders 33
1.6 Summary Of Changes 33

2 Research Methodology 35
2.1 Research Approach 35
Figure 2 Research Design 35
2.1.1 Secondary Data 36
2.1.2 Primary Data 37
Figure 3 Breakdown Of Primaries: Biologics Safety Testing Market 37
2.1.3 Data Triangulation Approach 38
2.2 Data Triangulation 38
Figure 4 Data Triangulation Methodology 38
2.3 Market Estimation Methodology 39
Figure 5 Market Size Estimation: Company Revenue Analysis-Based Estimation 39
Figure 6 Market Size Estimation: Segmental Analysis-Based Estimation 39
Figure 7 Biologics Safety Testing Market: Final Cagr Projection (2022−2027) 40
Figure 8 Biologics Safety Testing: Cagr Projection From Analysis Of Drivers, Restraints, Opportunities, And Challenges 41
2.4 Industry Insights 42
2.5 Research Assumptions 42
2.6 Recession Impact 42
Table 1 Global Inflation Rate Projection, 2024−2027 (% Growth) 42

3 Executive Summary 44
Figure 9 Biologics Safety Testing Market Share, By Product & Service (2021) 44
Figure 10 Biologics Safety Testing Market, By Application, 2022 Vs. 2027 (Usd Million) 45
Figure 11 Biologics Safety Testing Market, By Test Type, 2022 Vs. 2027 (Usd Million) 46
Figure 12 Biologics Safety Testing Market: Geographical Growth Opportunities 47

4 Premium Insights 48
4.1 Biologics Safety Testing Market Overview 48
Figure 13 Rising Development Of Biologics And Biosimilars To Drive Market 48
4.2 North America: Biologics Safety Testing Market, By Application And Country (2021) 49
Figure 14 Monoclonal Antibodies Manufacturing Segment Accounted For Largest Share In 2021 49
4.3 Biologics Safety Testing Market, By Test Type 50
Figure 15 Residual Host-Cell Proteins And Dna Detection Tests Segment To Register Highest Cagr During Forecast Period 50

5 Market Overview 51
5.1 Market Dynamics 51
Figure 16 Biologics Safety Testing Market: Drivers, Restraints, Opportunities, And Challenges 51
5.1.1 Drivers 52
5.1.1.1 Growing Development Of Biosimilars And Biologics 52
Table 2 List Of Biological License Application Approvals In Us, 2021 52
Table 3 List Of Biologics Approved By Us Fda (2021) 53
5.1.1.2 Growing Concerns Over Cell Culture Contamination 54
5.1.1.3 Rising Investments In Biopharmaceutical R&D 54
Table 4 Pharmaceutical R&D Spending, By Company, 2020 Vs. 2026 (Usd Billion) 54
Figure 17 Pharmaceutical & Biopharmaceutical R&D Expenditure,
2017–2024 55
5.1.2 Restraints 55
5.1.2.1 Shortage Of Skilled Professionals 55
5.1.3 Opportunities 56
5.1.3.1 Emerging Markets 56
5.1.3.2 Increasing Outsourcing Of Biopharmaceutical Activities To Cros 56
5.1.4 Challenges 57
5.1.4.1 High Cost Of Biologics 57
5.2 Pricing Analysis 57
Table 5 Average Selling Price Of Biologics Safety Testing Products
(2020-2021) 57
5.2.1 Pricing Trend Analysis 57
5.3 Value Chain Analysis 58
Figure 18 Biologics Safety Testing Market: Value Chain Analysis 58
5.4 Ecosystem Analysis 59
Figure 19 Biologics Safety Testing Market: Ecosystem Analysis 59
5.5 Trends/Disruptions Impacting Customers' Businesses 59
Figure 20 Revenue Shift For Biologics Safety Testing Providers 59
5.6 Patent Analysis 60
Figure 21 Top Applicants & Owners (Companies/Institutions) For Biologics Safety Patents (January 2012−November 2022) 60
Table 6 Biologics Safety Testing Market: Indicative List Of Patents 61
5.7 Regulatory Analysis 62
5.7.1 Us 62
5.7.2 Europe 63
5.7.3 Asia Pacific 64
5.7.4 Latin America 64
5.7.5 Middle East And Africa 64
5.7.6 Regulatory Bodies, Government Agencies, And Other Organizations 65
Table 7 North America: Regulatory Bodies, Government Agencies, And Other Organizations 65
Table 8 Europe: Regulatory Bodies, Government Agencies, And Other Organizations 65
Table 9 Asia Pacific: Regulatory Bodies, Government Agencies, And Other Organizations 66
Table 10 Rest Of The World: Regulatory Bodies, Government Agencies, And Other Organizations 66
5.8 Porter's Five Forces Analysis 67
Table 11 Biologics Safety Testing Market: Porter's Five Forces Analysis 67
5.8.1 Threat Of New Entrants 67
5.8.2 Threat Of Substitutes 67
5.8.3 Bargaining Power Of Buyers 67
5.8.4 Bargaining Power Of Suppliers 68
5.8.5 Intensity Of Competitive Rivalry 68
5.9 Key Conferences And Events In 2022–2023 68
Table 12 Biologics Safety Testing Market: Conferences And Events 68
5.10 Key Stakeholders And Buying Criteria 69
Figure 22 Influence Of Stakeholders On Buying Process For Products & Services 69
Figure 23 Buying Criteria For Biologics Safety Testing Products & Services 69

6 Biologics Safety Testing Market, By Product & Service 70
6.1 Introduction 71
Table 13 Biologics Safety Testing Market, By Product & Service, 2020–2027 (Usd Million) 71
6.2 Services 71
6.2.1 Increasing Outsourcing Of Services To Cros To Drive Market 71
Table 14 Biologics Safety Testing Services Market, By Region, 2020–2027 (Usd Million) 72
Table 15 North America: Biologics Safety Testing Services Market, By Country, 2020–2027 (Usd Million) 72
Table 16 Europe: Biologics Safety Testing Services Market, By Country, 2020–2027 (Usd Million) 72
Table 17 Asia Pacific: Biologics Safety Testing Services Market, By Country, 2020–2027 (Usd Million) 73
6.3 Consumables 73
6.3.1 Recurrent Purchase Of Assays, Kits, And Reagents To Drive Market 73
Table 18 Biologics Safety Testing Consumables Market, By Region, 2020–2027 (Usd Million) 74
Table 19 North America: Biologics Safety Testing Consumables Market, By Country, 2020–2027 (Usd Million) 74
Table 20 Europe: Biologics Safety Testing Consumables Market, By Country, 2020–2027 (Usd Million) 74
Table 21 Asia Pacific: Biologics Safety Testing Consumables Market, By Country, 2020–2027 (Usd Million) 75
6.4 Instruments 75
6.4.1 Longer Shelf Life Of Instruments To Restrain Market 75
Table 22 Biologics Safety Testing Instruments Market, By Region, 2020–2027 (Usd Million) 76
Table 23 North America: Biologics Safety Testing Instruments Market, By Country, 2020–2027 (Usd Million) 76
Table 24 Europe: Biologics Safety Testing Instruments Market, By Country, 2020–2027 (Usd Million) 76
Table 25 Asia Pacific: Biologics Safety Testing Instruments Market, By Country, 2020–2027 (Usd Million) 77

7 Biologics Safety Testing Market, By Test Type 78
7.1 Introduction 79
Table 26 Biologics Safety Testing Market, By Test Type, 2020–2027 (Usd Million) 79
7.2 Residual Host-Cell Proteins And Dna Detection Tests 79
7.2.1 Growing Use Of Rdna In Various Manufacturing Stages To Drive Market 79
Table 27 Residual Host-Cell Proteins And Dna Detection Tests Market, By Region, 2020–2027 (Usd Million) 80
Table 28 North America: Residual Host-Cell Proteins And Dna Detection Tests Market, By Country, 2020–2027 (Usd Million) 80
Table 29 Europe: Residual Host-Cell Proteins And Dna Detection Tests Market, By Country, 2020–2027 (Usd Million) 80
Table 30 Asia Pacific: Residual Host-Cell Proteins And Dna Detection Tests Market, By Country, 2020–2027 (Usd Million) 81
7.3 Mycoplasma Tests 81
7.3.1 Growing Concerns Over Cell Culture Contamination To Drive Market 81
Table 31 Mycoplasma Tests Market, By Region, 2020–2027 (Usd Million) 82
Table 32 North America: Mycoplasma Tests Market, By Country, 2020–2027 (Usd Million) 82
Table 33 Europe: Mycoplasma Tests Market, By Country, 2020–2027 (Usd Million) 82
Table 34 Asia Pacific: Mycoplasma Tests Market, By Country, 2020–2027 (Usd Million) 83
7.4 Sterility Tests 83
7.4.1 Mandatory Testing Conducted For Drug Development & Production To Drive Market 83
Table 35 Sterility Tests Market, By Region, 2020–2027 (Usd Million) 84
Table 36 North America: Sterility Tests Market, By Country, 2020–2027 (Usd Million) 84
Table 37 Europe: Sterility Tests Market, By Country, 2020–2027 (Usd Million) 84
Table 38 Asia Pacific: Sterility Tests Market, By Country, 2020–2027 (Usd Million) 85
7.5 Endotoxin Tests 85
7.5.1 Rising Demand For Lal Testing To Support Market Growth 85
Table 39 Endotoxin Tests Market, By Region, 2020–2027 (Usd Million) 86
Table 40 North America: Endotoxin Tests Market, By Country, 2020–2027 (Usd Million) 86
Table 41 Europe: Endotoxin Tests Market, By Country, 2020–2027 (Usd Million) 86
Table 42 Asia Pacific: Endotoxin Tests Market, By Country, 2020–2027 (Usd Million) 87
7.6 Virus Safety Tests 87
7.6.1 Rising Uptake In Vaccine Development And Cell & Gene Therapy To Support Market 87
Table 43 Virus Safety Tests Market, By Region, 2020–2027 (Usd Million) 88
Table 44 North America: Virus Safety Tests Market, By Country, 2020–2027 (Usd Million) 88
Table 45 Europe: Virus Safety Tests Market, By Country, 2020–2027 (Usd Million) 88
Table 46 Asia Pacific: Virus Safety Tests Market, By Country, 2020–2027 (Usd Million) 89
7.7 Bioburden Tests 89
7.7.1 Growing Concerns For Drug Safety Standards To Propel Market 89
Table 47 Bioburden Tests Market, By Region, 2020–2027 (Usd Million) 89
Table 48 North America: Bioburden Tests Market, By Country, 2020–2027 (Usd Million) 90
Table 49 Europe: Bioburden Tests Market, By Country, 2020–2027 (Usd Million) 90
Table 50 Asia Pacific: Bioburden Tests Market, By Country, 2020–2027 (Usd Million) 90
7.8 Other Biologics Safety Tests 91
Table 51 Other Biologics Safety Tests Market, By Region, 2020–2027 (Usd Million) 91
Table 52 North America: Other Biologics Safety Tests Market, By Country, 2020–2027 (Usd Million) 91
Table 53 Europe: Other Biologics Safety Tests Market, By Country, 2020–2027 (Usd Million) 92
Table 54 Asia Pacific: Other Biologics Safety Tests Market, By Country, 2020–2027 (Usd Million) 92

8 Biologics Safety Testing Market, By Application 93
8.1 Introduction 94
Table 55 Biologics Safety Testing Market, By Application, 2020–2027 (Usd Million) 94
8.2 Monoclonal Antibodies Development And Manufacturing 94
8.2.1 Rising Approvals For Biosimilar Mabs To Drive Market 94
Table 56 Biologics Safety Testing Market For Monoclonal Antibodies Development And Manufacturing, By Region, 2020–2027 (Usd Million) 95
Table 57 North America: Biologics Safety Testing Market For Monoclonal Antibodies Development And Manufacturing, By Country, 2020–2027 (Usd Million) 95
Table 58 Europe: Biologics Safety Testing Market For Monoclonal Antibodies Development And Manufacturing, By Country, 2020–2027 (Usd Million) 96
Table 59 Asia Pacific: Biologics Safety Testing Market For Monoclonal Antibodies Development And Manufacturing, By Country, 2020–2027 (Usd Million) 96
8.3 Vaccine Development And Manufacturing 96
8.3.1 Growing Prevalence Of Infectious Diseases To Drive Market 96
Table 60 Biologics Safety Testing Market For Vaccine Development And Manufacturing, By Region, 2020–2027 (Usd Million) 97
Table 61 North America: Biologics Safety Testing Market For Vaccine Development And Manufacturing, By Country, 2020–2027 (Usd Million) 97
Table 62 Europe: Biologics Safety Testing Market For Vaccine Development And Manufacturing, By Country, 2020–2027 (Usd Million) 98
Table 63 Asia Pacific: Biologics Safety Testing Market For Vaccine Development And Manufacturing, By Country, 2020–2027 (Usd Million) 98
8.4 Cellular & Gene Therapy Product Development And Manufacturing 98
8.4.1 Rising Adoption Of Cellular Immunotherapies For Cancer Treatment To Drive Market 98
Table 64 Biologics Safety Testing Market For Cellular & Gene Therapy Product Development And Manufacturing, By Region, 2020–2027 (Usd Million) 99
Table 65 North America: Biologics Safety Testing Market For Cellular & Gene Therapy Products Development And Manufacturing, By Country, 2020–2027 (Usd Million) 99
Table 66 Europe: Biologics Safety Testing Market For Cellular & Gene Therapy Product Development And Manufacturing, By Country, 2020–2027 (Usd Million) 100
Table 67 Asia Pacific: Biologics Safety Testing Market For Cellular & Gene Therapy Products Development And Manufacturing, By Country, 2020–2027 (Usd Million) 100
8.5 Blood & Blood Product Development And Manufacturing 100
8.5.1 Rising Uptake Of Sterility Tests To Support Market Growth 100
Table 68 Biologics Safety Testing Market For Blood & Blood Product Development And Manufacturing, By Region, 2020–2027 (Usd Million) 101
Table 69 North America: Biologics Safety Testing Market For Blood & Blood Product Development And Manufacturing, By Country, 2020–2027 (Usd Million) 101
Table 70 Europe: Biologics Safety Testing Market For Blood & Blood Product Development And Manufacturing, By Country, 2020–2027 (Usd Million) 102
Table 71 Asia Pacific: Biologics Safety Testing Market For Blood & Blood Product Development And Manufacturing, By Country, 2020–2027 (Usd Million) 102
8.6 Other Applications 102
Table 72 Biologics Safety Testing Market For Other Applications, By Region, 2020–2027 (Usd Million) 103
Table 73 North America: Biologics Safety Testing Market For Other Applications, By Country, 2020–2027 (Usd Million) 103
Table 74 Europe: Biologics Safety Testing Market For Other Applications, By Country, 2020–2027 (Usd Million) 104
Table 75 Asia Pacific: Biologics Safety Testing Market For Other Applications, By Country, 2020–2027 (Usd Million) 104

9 Biologics Safety Testing Market, By End User 105
9.1 Introduction 106
Table 76 Biologics Safety Testing Market, By End User, 2020–2027 (Usd Million) 106
9.2 Pharmaceutical & Biopharmaceutical Companies 106
9.2.1 Growing R&D Expenditure For Drug Development To Drive Market 106
Figure 24 Pharmaceutical R&D Spending (2014–2028) 107
Table 77 Biologics Safety Testing Market For Pharmaceutical & Biopharmaceutical Companies, By Region, 2020–2027 (Usd Million) 107
Table 78 North America: Biologics Safety Testing Market For Pharmaceutical & Biopharmaceutical Companies, By Country, 2020–2027 (Usd Million) 108
Table 79 Europe: Biologics Safety Testing Market For Pharmaceutical & Biopharmaceutical Companies, By Country, 2020–2027 (Usd Million) 108
Table 80 Asia Pacific: Biologics Safety Testing Market For Pharmaceutical & Biopharmaceutical Companies, By Country, 2020–2027 (Usd Million) 108
9.3 Contract Research Organizations And Contract Development & Manufacturing Organizations (Cros And Cdmos) 109
9.3.1 Ability To Provide Specialized Manufacturing And Safety Testing Technologies To Drive Market 109
Table 81 Biologics Safety Testing Market For Cros And Cdmos, By Region, 2020–2027 (Usd Million) 109
Table 82 North America: Biologics Safety Testing Market For Crs And Cdmos, By Country, 2020–2027 (Usd Million) 110
Table 83 Europe: Biologics Safety Testing Market For Cros And Cdmos,
By Country, 2020–2027 (Usd Million) 110
Table 84 Asia Pacific: Biologics Safety Testing Market For Cros And Cdmos, By Country, 2020–2027 (Usd Million) 110
9.4 Academic & Research Institutes 111
9.4.1 Availability Of Advanced Equipment And Specialized R&D Personnel To Support Market Growth 111
Table 85 Biologics Safety Testing Market For Academic & Research Institutes, By Region, 2020–2027 (Usd Million) 111
Table 86 North America: Biologics Safety Testing Market For Academic & Research Institutes, By Country, 2020–2027 (Usd Million) 112
Table 87 Europe: Biologics Safety Testing Market For Academic & Research Institutes, By Country, 2020–2027 (Usd Million) 112
Table 88 Asia Pacific: Biologics Safety Testing Market For Academic & Research Institutes, By Country, 2020–2027 (Usd Million) 112

10 Biologics Safety Testing Market, By Region 113
10.1 Introduction 114
Table 89 Biologics Safety Testing Market, By Region, 2020–2027 (Usd Million) 114
10.2 North America 114
Figure 25 Biologics Safety Testing Market: North America Market Snapshot 115
Table 90 North America: Biologics Safety Testing Market, By Country, 2020–2027 (Usd Million) 116
Table 91 North America: Biologics Safety Testing Market, By Product & Service, 2020–2027 (Usd Million) 116
Table 92 North America: Biologics Safety Testing Market, By Test Type, 2020–2027 (Usd Million) 116
Table 93 North America: Biologics Safety Testing Market, By Application, 2020–2027 (Usd Million) 117
Table 94 North America: Biologics Safety Testing Market, By End User, 2020–2027 (Usd Million) 117
10.2.1 Us 118
10.2.1.1 High Investments In Biopharmaceutical R&D To Drive Market 118
Table 95 Us: Biologics Safety Testing Market, By Product & Service,
2020–2027 (Usd Million) 118
Table 96 Us: Biologics Safety Testing Market, By Test Type,
2020–2027 (Usd Million) 119
Table 97 Us: Biologics Safety Testing Market, By Application,
2020–2027 (Usd Million) 119
Table 98 Us: Biologics Safety Testing Market, By End User,
2020–2027 (Usd Million) 120
10.2.2 Canada 120
10.2.2.1 Presence Of R&D Clusters And Growing Life Sciences Research To Drive Market 120
Table 99 Canada: Biologics Safety Testing Market, By Product & Service, 2020–2027 (Usd Million) 121
Table 100 Canada: Biologics Safety Testing Market, By Test Type,
2020–2027 (Usd Million) 121
Table 101 Canada: Biologics Safety Testing Market, By Application,
2020–2027 (Usd Million) 122
Table 102 Canada: Biologics Safety Testing Market, By End User,
2020–2027 (Usd Million) 122
10.2.3 North America: Recession Impact 123
10.3 Europe 124
Table 103 Europe: Biologics Safety Testing Market, By Country,
2020–2027 (Usd Million) 124
Table 104 Europe: Biologics Safety Testing Market, By Product & Service, 2020–2027 (Usd Million) 125
Table 105 Europe: Biologics Safety Testing Market, By Test Type, 2020–2027 (Usd Million) 125
Table 106 Europe: Biologics Safety Testing Market, By Application, 2020–2027 (Usd Million) 126
Table 107 Europe: Biologics Safety Testing Market, By End User, 2020–2027 (Usd Million) 126
10.3.1 Germany 127
10.3.1.1 Favorable R&D Funding By Federal And State Governments To Propel Market 127
Table 108 Germany: Biologics Safety Testing Market, By Product & Service, 2020–2027 (Usd Million) 127
Table 109 Germany: Biologics Safety Testing Market, By Test Type, 2020–2027 (Usd Million) 128
Table 110 Germany: Biologics Safety Testing Market, By Application, 2020–2027 (Usd Million) 128
Table 111 Germany: Biologics Safety Testing Market, By End User, 2020–2027 (Usd Million) 129
10.3.2 Uk 129
10.3.2.1 Growing Focus On Investments In Vaccine Manufacturing To Drive Market 129
Table 112 Uk: Biologics Safety Testing Market, By Product & Service, 2020–2027 (Usd Million) 130
Table 113 Uk: Biologics Safety Testing Market, By Test Type, 2020–2027 (Usd Million) 130
Table 114 Uk: Biologics Safety Testing Market, By Application, 2020–2027 (Usd Million) 131
Table 115 Uk: Biologics Safety Testing Market, By End User, 2020–2027 (Usd Million) 131
10.3.3 France 131
10.3.3.1 Government Initiatives To Strengthen R&D Activities To Support Market Growth 131
Table 116 France: Biologics Safety Testing Market, By Product & Service, 2020–2027 (Usd Million) 132
Table 117 France: Biologics Safety Testing Market, By Test Type, 2020–2027 (Usd Million) 132
Table 118 France: Biologics Safety Testing Market, By Application, 2020–2027 (Usd Million) 133
Table 119 France: Biologics Safety Testing Market, By End User, 2020–2027 (Usd Million) 133
10.3.4 Italy 134
10.3.4.1 Favorable Government Support For Establishment Of Biotech Startups To Propel Market 134
Table 120 Italy: Biologics Safety Testing Market, By Product & Service, 2020–2027 (Usd Million) 134
Table 121 Italy: Biologics Safety Testing Market, By Test Type, 2020–2027 (Usd Million) 135
Table 122 Italy: Biologics Safety Testing Market, By Application, 2020–2027 (Usd Million) 135
Table 123 Italy: Biologics Safety Testing Market, By End User, 2020–2027 (Usd Million) 136
10.3.5 Spain 136
10.3.5.1 Increasing Biologics Production And Outsourcing Testing Services To Support Market Growth 136
Table 124 Spain: Biologics Safety Testing Market, By Product & Service, 2020–2027 (Usd Million) 137
Table 125 Spain: Biologics Safety Testing Market, By Test Type, 2020–2027 (Usd Million) 137
Table 126 Spain: Biologics Safety Testing Market, By Application, 2020–2027 (Usd Million) 138
Table 127 Spain: Biologics Safety Testing Market, By End User, 2020–2027 (Usd Million) 138
10.3.6 Rest Of Europe 138
Table 128 Rest Of Europe: Biologics Safety Testing Market, By Product & Service, 2020–2027 (Usd Million) 139
Table 129 Rest Of Europe: Biologics Safety Testing Market, By Test Type, 2020–2027 (Usd Million) 139
Table 130 Rest Of Europe: Biologics Safety Testing Market, By Application, 2020–2027 (Usd Million) 140
Table 131 Rest Of Europe: Biologics Safety Testing Market, By End User, 2020–2027 (Usd Million) 140
10.3.7 Europe: Recession Impact 141
10.4 Asia Pacific 141
Figure 26 Biologics Safety Testing Market: Asia Pacific Market Snapshot 142
Table 132 Asia Pacific: Biologics Safety Testing Market, By Country, 2020–2027 (Usd Million) 143
Table 133 Asia Pacific: Biologics Safety Testing Market, By Product & Service, 2020–2027 (Usd Million) 143
Table 134 Asia Pacific: Biologics Safety Testing Market, By Test Type, 2020–2027 (Usd Million) 143
Table 135 Asia Pacific: Biologics Safety Testing Market, By Application, 2020–2027 (Usd Million) 144
Table 136 Asia Pacific: Biologics Safety Testing Market, By End Users, 2020–2027 (Usd Million) 144
10.4.1 China 145
10.4.1.1 Rising Approvals For Drug Applications And High R&D Innovation To Drive Market 145
Table 137 China: Biologics Safety Testing Market, By Product & Service, 2020–2027 (Usd Million) 145
Table 138 China: Biologics Safety Testing Market, By Test Type, 2020–2027 (Usd Million) 146
Table 139 China: Biologics Safety Testing Market, By Application, 2020–2027 (Usd Million) 146
Table 140 China: Biologics Safety Testing Market, By End User, 2020–2027 (Usd Million) 147
10.4.2 Japan 147
10.4.2.1 Rising Investments For Establishment Of Cell & Gene Therapy Facilities To Propel Market 147
Table 141 Japan: Biologics Safety Testing Market, By Product & Service, 2020–2027 (Usd Million) 147
Table 142 Japan: Biologics Safety Testing Market, By Test Type, 2020–2027 (Usd Million) 148
Table 143 Japan: Biologics Safety Testing Market, By Application, 2020–2027 (Usd Million) 148
Table 144 Japan: Biologics Safety Testing Market, By End User, 2020–2027 (Usd Million) 149
10.4.3 India 149
10.4.3.1 High Demand For Export Of Pharmaceuticals And Vaccines To Drive Market 149
Table 145 India: Biologics Safety Testing Market, By Product & Service, 2020–2027 (Usd Million) 150
Table 146 India: Biologics Safety Testing Market, By Test Type, 2020–2027 (Usd Million) 150
Table 147 India: Biologics Safety Testing Market, By Application, 2020–2027 (Usd Million) 151
Table 148 India: Biologics Safety Testing Market, By End User, 2020–2027 (Usd Million) 151
10.4.4 Rest Of Asia Pacific 151
Table 149 Rest Of Asia Pacific: Biologics Safety Testing Market, By Product & Service, 2020–2027 (Usd Million) 152
Table 150 Rest Of Asia Pacific: Biologics Safety Testing Market, By Test Type, 2020–2027 (Usd Million) 152
Table 151 Rest Of Asia Pacific: Biologics Safety Testing Market, By Application, 2020–2027 (Usd Million) 153
Table 152 Rest Of Asia Pacific: Biologics Safety Testing Market, By End User, 2020–2027 (Usd Million) 153
10.4.5 Asia Pacific: Recession Impact 154
10.5 Latin America 154
10.5.1 Growing Approval Of Biosimilars To Support Market Growth 154
Table 153 Latin America: Biologics Safety Testing Market, By Product & Service, 2020–2027 (Usd Million) 155
Table 154 Latin America: Biologics Safety Testing Market, By Test Type, 2020–2027 (Usd Million) 155
Table 155 Latin America: Biologics Safety Testing Market, By Application, 2020–2027 (Usd Million) 156
Table 156 Latin America: Biologics Safety Testing Market, By End User, 2020–2027 (Usd Million) 156
10.5.2 Latin America: Recession Impact 157
10.6 Middle East & Africa 157
10.6.1 Rising Focus On Drug Discovery And Development To Support Market Growth 157
Table 157 Middle East & Africa: Biologics Safety Testing Market, By Product & Service, 2020–2027 (Usd Million) 158
Table 158 Middle East & Africa: Biologics Safety Testing Market, By Test Type, 2020–2027 (Usd Million) 158
Table 159 Middle East & Africa: Biologics Safety Testing Market, By Application, 2020–2027 (Usd Million) 159
Table 160 Middle East & Africa: Biologics Safety Testing Market, By End User, 2020–2027 (Usd Million) 159
10.6.2 Middle East & Africa: Recession Impact 159

11 Competitive Landscape 161
11.1 Overview 161
11.2 Right-To-Win Strategies Adopted By Key Players 161
Figure 27 Biologics Safety Testing Market: Key Player Strategies (2019–2022) 162
11.3 Market Share Analysis 163
Figure 28 Biologics Safety Testing Market: Market Share Analysis Of Key Players, 2021 (Top Eight) 163
Table 161 Biologics Safety Testing Market: Intensity Of Competitive Rivalry 164
11.4 Revenue Share Analysis Of Key Players 165
Figure 29 Biologics Safety Testing Market: Revenue Share Analysis Of Key Players (Top Eight) 165
11.5 Company Evaluation Matrix 165
11.5.1 Stars 166
11.5.2 Emerging Leaders 166
11.5.3 Pervasive Players 166
11.5.4 Participants 166
Figure 30 Biologics Safety Testing Market: Company Evaluation Matrix, 2021 167
11.6 Competitive Leadership Mapping For Startups 167
11.6.1 Progressive Companies 167
11.6.2 Starting Blocks 167
11.6.3 Dynamic Companies 168
11.6.4 Responsive Companies 168
Figure 31 Biologics Safety Testing: Competitive Leadership Mapping For Startups (2021) 168
11.7 Competitive Benchmarking 169
11.7.1 Company Product Footprint 169
Table 162 Biologics Safety Testing Market: Product Portfolio Analysis 169
11.7.2 Company Test Type Footprint 170
Table 163 Biologics Safety Testing Market: Test Type Analysis 170
11.7.3 Company Geographic Footprint 171
Table 164 Biologics Safety Testing Market: Geographic Analysis 171
11.7.4 Overall Company Footprint (25 Companies) 172
Table 165 Biologics Safety Testing Market: Company Footprint 172
11.7.4.1 Competitive Benchmarking For Startups 173
Table 166 Biologics Safety Testing Market: Key Startups 173
Table 167 Biologics Safety Testing Market: Competitive Benchmarking Of Key Startups 174
11.8 Competitive Scenario 175
11.8.1 Biologics Safety Testing Market: Product Launches (January 2019−December 2022) 175
11.8.2 Biologics Safety Testing Market: Deals (January 2019−December 2022) 176
11.8.3 Biologics Safety Testing Market: Other Developments (January 2019−December 2022) 177

12 Company Profiles 178
12.1 Key Players 178
(Business Overview, Products Offered, Recent Developments, And Mnm View (Key Strengths/Right To Win, Strategic Choices Made, And Weaknesses And Competitive Threats))*
12.1.1 Charles River Laboratories 178
Table 168 Charles River Laboratories: Business Overview 178
Figure 32 Charles River Laboratories: Company Snapshot (2021) 179
12.1.2 Lonza 184
Table 169 Lonza: Business Overview 184
Figure 33 Lonza: Company Snapshot (2021) 185
12.1.3 Thermo Fisher Scientific, Inc. 189
Table 170 Thermo Fisher Scientific: Business Overview 189
Figure 34 Thermo Fisher Scientific, Inc.: Company Snapshot (2020) 190
12.1.4 Merck Kgaa 193
Table 171 Merck Kgaa: Business Overview 193
Figure 35 Merck Kgaa: Company Snapshot (2021) 194
12.1.5 Laboratory Corporation Of America Holdings (Labcorp) 197
Figure 36 Laboratory Corporation Of America Holdings: Company Snapshot (2021) 198
12.1.6 Sgs Sa 201
Table 173 Sgs Sa: Business Overview 201
Figure 37 Sgs Sa: Company Snapshot (2021) 202
12.1.7 Eurofins Scientific 204
Table 174 Eurofins Scientific: Business Overview 204
Figure 38 Eurofins Scientific: Company Snapshot (2021) 205
12.1.8 Wuxi Apptec 207
Table 175 Wuxi Apptec: Business Overview 207
Figure 39 Wuxi Apptec: Company Snapshot (2021) 208
12.1.9 Associates Of Cape Cod, Inc. 210
Table 176 Associates Of Cape Cod, Inc.: Business Overview 210
12.1.10 Biomérieux Sa 212
Table 177 Biomérieux Sa: Business Overview 212
Figure 40 Biomérieux Sa: Company Snapshot (2021) 213
12.1.11 Samsung Biologics 215
Table 178 Samsung Biologics: Business Overview 215
Figure 41 Samsung Biologics: Company Snapshot (2021) 216
12.1.12 Genscript 218
Table 179 Genscript: Business Overview 218
Figure 42 Genscript: Company Snapshot (2021) 219
12.1.13 Sartorius Ag 221
Table 180 Sartorius Ag: Business Overview 221
Figure 43 Sartorius Ag: Company Snapshot (2021) 222
12.1.14 F. Hoffmann-La Roche Ltd. 224
Table 181 F. Hoffmann-La Roche Ltd.: Business Overview 224
Figure 44 F. Hoffmann-La Roche Ltd.: Company Snapshot (2021) 225
12.1.15 Pacific Biolabs 227
Table 182 Pacific Biolabs: Business Overview 227
12.1.16 Nelson Laboratories, Llc (Part Of Sotera Health) 229
Table 183 Nelson Laboratories: Business Overview 229
12.1.17 Agilent Technologies, Inc. 231
Table 184 Agilent Technologies: Business Overview 231
Figure 45 Agilent Technologies: Company Snapshot (2021) 232
12.1.18 Maravai Lifesciences 234
Table 185 Maravai Lifesciences: Business Overview 234
Figure 46 Maravai Lifesciences: Company Snapshot (2021) 235
12.2 Other Players 237
12.2.1 Qiagen 237
12.2.2 Bio-Rad Laboratories, Inc. 238
12.2.3 Microcoat Biotechnologie Gmbh 239
12.2.4 Invivogen 240
12.2.5 Promocell Gmbh 241
12.2.6 Accugen Laboratories, Inc. 242
12.2.7 Fujifilm Wako Pure Chemical Corporation 242
12.2.8 Almac Group 243
*Details On Business Overview, Products Offered, Recent Developments, And Mnm View (Key Strengths/Right To Win, Strategic Choices Made, And Weaknesses And Competitive Threats) Might Not Be Captured In Case Of Unlisted Companies.

13 Appendix 244
13.1 Discussion Guide 244
13.2 Knowledgestore: Marketsandmarkets’ Subscription Portal 246
13.3 Customization Options 248
13.4 Related Reports 248
13.5 Author Details 249

  • Global Cytokine Inhibitor Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Cytokine Inhibitor market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The development prospects of cytokine inhibitors are very broad, and these drugs have many medical applications and researches. Cytokine inhibitors can reduce The activity of cytokines, thereby inhibiting their role in immune responses and reducing The activation of immune cells and The occurrence o......
  • Global Microbial Growth Media Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    Microbial Growth Media is a nutrient component required by microorganisms, containing a variety of trace elements and trace elements, such as copper, iron, zinc, cobalt, manganese, etc. The global Microbial Growth Media market was valued at US$ 8007 million in 2023 and is anticipated to reach US$ 11530 million by 2030, witnessing a CAGR of 5.3% during The forecast period 2024-2030. The market for microbial growth media is essential in microbiology and biotechnology rese......
  • Global Protein Biochip Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 92
    Protein Biochip is a small Protein array used to quickly detect a large number of unknown proteins. It works in a similar way to a DNA chip. First, a large number of known proteins (such as monoclonal antibodies) are placed on a small substrate and then exposed to and reacted with The unknown protein sample. Due to The specific binding between The antigen and The antibody, it can finally be detected by means of laser. The global Protein Biochip market was valued at US$ 145 million i......
  • Global Isothermal Nucleic Acid Amplification Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 103
    Isothermal nucleic acid amplification is referred to isothermal nucleic acid amplification technology. And in this report, we get The statistics on reagents used in isothermal nucleic acid amplification technology. Nucleic acid isothermal amplification is a newer technique that amplifies DNA or RNA specific fragment from few copies to billion-fold copies under a one temperature condition, unlike PCR amplification that needs at least 30-35 thermal cycles to accomplish The reaction. T......
  • Global Microfluidics Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 134
    According to our LPI (LP Information) latest study, the global Microfluidics market size was valued at US$ 3118.7 million in 2023. With growing demand in downstream market, the Microfluidics is forecast to a readjusted size of US$ 7707.1 million by 2030 with a CAGR of 13.8% during review period. The research report highlights the growth potential of the global Microfluidics market. Microfluidics are expected to show stable growth in the future market. However, product differentiation, re......
  • Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 122
    According to our LPI (LP Information) latest study, the global Isothermal Nucleic Acid Amplification Technology (INAAT) market size was valued at US$ 6141.3 million in 2023. With growing demand in downstream market, the Isothermal Nucleic Acid Amplification Technology (INAAT) is forecast to a readjusted size of US$ 11250 million by 2030 with a CAGR of 9.0% during review period. The research report highlights the growth potential of the global Isothermal Nucleic Acid Amplification Technol......
  • Global Cytokines Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 119
    According to our LPI (LP Information) latest study, the global Cytokines market size was valued at US$ 203730 million in 2023. With growing demand in downstream market, the Cytokines is forecast to a readjusted size of US$ 611910 million by 2030 with a CAGR of 17.0% during review period. The research report highlights the growth potential of the global Cytokines market. Cytokines are expected to show stable growth in the future market. However, product differentiation, reducing costs, an......
  • Global Western Blot Imagers Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 94
    According to our LPI (LP Information) latest study, the global Western Blot Imagers market size was valued at US$ 406 million in 2023. With growing demand in downstream market, the Western Blot Imagers is forecast to a readjusted size of US$ 578.4 million by 2030 with a CAGR of 5.2% during review period. The research report highlights the growth potential of the global Western Blot Imagers market. Western Blot Imagers are expected to show stable growth in the future market. However, prod......
  • Global Procalcitonin Antibody Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 125
    According to our LPI (LP Information) latest study, the global Procalcitonin Antibody market size was valued at US$ million in 2023. With growing demand in downstream market, the Procalcitonin Antibody is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Procalcitonin Antibody market. Procalcitonin Antibody are expected to show stable growth in the future market. However, product di......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs